Synapse Open Synapse
Patents & IP

Ones to Watch Netherlands 2026: Barbara Mooij

JuVE Patent · · 4 min read

Last Thursday, a few champagne corks popped at Brinkhof’s Amsterdam office. The firm’s client, Halozyme, secured a significant victory. The District Court The Hague handed Halozyme a win in its global dispute with MSD over the subcutaneous version of the blockbuster cancer drug Keytruda.

Same story elsewhere

Latest from JuVE Patent